日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy in locally advanced esophageal squamous cell carcinoma

局部晚期食管鳞状细胞癌新辅助免疫化疗与化疗生存结果的比较

Sun, Yang; Yang, Hongying; Wang, Jing; Lou, Hanmei; Li, Dan; Wang, Ke; Zhang, Hui; Wu, Tao; Li, Yuzhi; Wang, Chunyan; Li, Guiling; Wang, Yifeng; Li, Dapeng; Tang, Ying; Pan, Mei; Cai, Hongyi; Wang, Weihu; Yang, Bing; Qian, Hua; Tian, Qiuhong; Yao, Desheng; Cheng, Ying; Wei, Bing; Li, Xiumin; Wang, Tao; Hao, Min; Wang, Xiaohong; Wang, Tiejun; Liu, Chang; Zhu, Hong; Zhu, Lijing; Liu, Xianling; Li, Yunxia; Chen, Lihong; Li, Qingshan; Yan, Xiaojian; Wang, Fei; Cai, Hongbing; Zhang, Yunyan; Liang, Zhiqing; Liu, Funan; Huang, Yi; Xia, Bairong; Qu, Pengpeng; Zhu, Genhai; Chen, Youguo; Song, Kun; Sun, Meili; Chen, Zhengzheng; Zhou, Qiang; Hu, Lina; Abulizi, Guzhalinuer; Guo, Hongyan; Liao, Sihai; Ye, Yijing; Yan, Ping; Tang, Qiu; Sun, Guoping; Liu, Ting; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin M; Li, Baiyong; Xia, Michelle; Wu, Xiaohua; Tian, Yichun; Wang, Xian; Lu, Zhaoxin; Mi, Yaqing; Zhou, Shaobo; Xu, Weili; Wolfe, Stanley B; Wei, Lawrence; Hayanga, JW; Chauhan, Dhaval; Dans, Nestor F; Mascio, Christopher E; Rankin, J Scott; Badhwar, Vinay; Mehaffey, J Hunter; Cui, Xinrun; Wang, Yaqi; Yan, Shi; Liu, Bing; Li, Xiang; Tao, Ye; Wang, Quanne; Du, Haoxuan; Li, Shaolei; Wu, Nan

Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial

聚乙二醇化脂质体阿霉素联合卡铂与紫杉醇联合卡铂作为上皮性卵巢癌一线治疗方案的比较(CGCS-04):一项多中心随机临床试验

Shen, Yuanming; Tu, Nalan; Kong, Beihua; Xia, Bairong; Zou, Yonghui; Yin, Rutie; Li, Qingshui; Yue, Ying; Kang, Shan; Wang, Ke; He, Liping; Wang, Shixuan; Meng, Yuanguang; Qu, Pengpeng; Huang, Xianghua; Guo, Ruixia; Yan, Ping; Pan, Mei; Cheng, Wenjun; Lou, Ge; Wang, Zehua

Pan-Cancer Analysis of WRN: From Multi-Omics Biomarker Discovery to Therapy-Guiding Functional Evidence

WRN的泛癌分析:从多组学生物标志物发现到指导治疗的功能证据

Yao, Qing-Qing; Qi, Yue; Shi, Pei-Qin; Yang, Zi-Ye; Qu, Pengpeng; Zhang, Wen-Wen

A systematic CRISPR screen reveals an NBL1-mediated Jak/Stat3 crosstalk to promote ovarian cancer metastasis

系统性 CRISPR 筛选揭示 NBL1 介导的 Jak/Stat3 串扰促进卵巢癌转移

Qi, Yue; Zhang, Wenwen; Li, Xinyu; Shi, Yi; Qu, Pengpeng

Impact of the microcystic, elongated, and fragmented invasion pattern on prognosis in endometrial carcinoma: a comprehensive meta-analysis

微囊性、细长型和碎片状浸润模式对子宫内膜癌预后的影响:一项综合荟萃分析

Zhou, Li; Li, Chengyao; Zhao, Jianguo; Li, Pu; Qu, Pengpeng

CS Ratio is an immune-related prognostic biomarker for cervical cancer

CS 比值是宫颈癌的一种免疫相关预后生物标志物。

Shi, Peiqin; Zhang, Wenwen; Yao, Qingqing; Yuan, Zhanna; Wang, Jiaqi; Yang, Ziye; Qu, Pengpeng

Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer

更正:CS 比值是宫颈癌的一种免疫相关预后生物标志物

Shi, Peiqin; Zhang, Wenwen; Yao, Qingqing; Yuan, Zhanna; Wang, Jiaqi; Yang, Ziye; Qu, Pengpeng

Impact of single-site distant metastases on prognosis in advanced ovarian cancer: a Surveillance, Epidemiology, and End Results population-based study

单部位远处转移对晚期卵巢癌预后的影响:一项基于监测、流行病学和最终结果人群的研究

Yuan, Zhanna; Shi, Peiqin; Zhang, Wenwen; Qu, Pengpeng

The development and validation of a novel programmed cell death-related signature based on machine learning analysis of 15 programmed cell death patterns for predicting prognosis and therapeutic response in high-grade serous ovarian carcinoma

基于机器学习分析15种程序性细胞死亡模式,开发并验证了一种新型程序性细胞死亡相关特征,用于预测高级别浆液性卵巢癌的预后和治疗反应。

Zhang, Zhidong; Zhang, Wenwen; Yao, Ailin; Qu, Pengpeng

Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer.

血清来源的外显子寡核苷酸R-188-3p是一种有前景的早期卵巢癌新型生物标志物

Wang Mingyu, Zhang Wenwen, Cheng Guangyan, Xu Juan, Qu Pengpeng